Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis

Magnetic Resonance in Medicine

Volumn 50, Issue 1, 2003, Pages 190-195

  Inglese, Matilde ^a   Li, Belinda S Y ^a   Rusinek, Henry ^a   Babb, James S ^a   Grossman, Robert I ^a   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain atrophy; Brain MR spectroscopy (MRS); Metabolite quantification; Multiple sclerosis (MS); Proton MRS; Relapsing remitting MS

Indexed keywords

BIOMOLECULES; CHROMIUM; CHROMIUM METALLOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY;

BRAIN ATROPHY; BRAIN MR; MULTIPLE SCLEROSIS; PROTON MRS; RELAPSING-REMITTING MS;

METABOLITES;

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN LEVEL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DISEASE ACTIVITY; FEMALE; GLIOSIS; GRAY MATTER; HUMAN; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RECURRENT DISEASE; REMISSION; REMYELINIZATION; WHITE MATTER;

EID: 0037925129     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10481     Document Type: Article

References (20)

1. Hauser SL. Multiple sclerosis and other demyelinating diseases. In: Isselbacher KJ, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine. New York: McGraw-Hill; 1994. p 2287-2295.
2. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
3. Filippi M. Linking structural, metabolic and functional changes in multiple sclerosis. Eur J Neurol 2001;8:291-297.
4. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91.
5. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluations of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990;14:154-159.
6. Gonen O, Catalaa I, Babb JS, Ge Y, Mannon LJ, Kolson DL, Grossman RI. Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 2000;54:15-19.
7. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
8. Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 1994;36:157-165.
9. Rooney WD, Goodkin DE, Schuff N, Meyerhoff DJ, Norman D, Weiner MW. 1H MRSI of normal appearing white matter in multiple sclerosis. Mult Scler 1997;3:231-237.
10. Gonen O, Murdoch JB, Stoyanova R, Goelman G. 3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D chemical shift imaging. Magn Reson Med 1998;39:34-40.
11. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis. III. Application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822-831.
12. Barker PB, Blackband SJ, Chatham JC, Mathews VP, Bryan RN. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 1993;6:89-94.
13. Kreis R, Ernst T, Ross BD. Absolute concentrations of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson 1993;102:9-19.
14. Hutchinson M, Rusinek H, Nenov VI, Feinberg DA, Johnson G. Segmentation analysis in functional MRI: activation sensitivity and gray-matter specificity of RARE and FLASH. J Magn Reson Imag 1997;7:361-364.
15. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, Bruck W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. Am J Neuroradiol 1999;20:1619-1627.
16. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45.
17. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52.
18. Mader I, Roser W, Kappos L, Hagberg G, Seelig J, Radue EW, Steinbrich W. Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. Am J Neuroradiol 2000;21:1220-1227.
19. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
20. 1H spectroscopy imaging at 4.1 T. Magn Reson Med 1996;36:72-77.